Characteristic | Remission group N = 26 | Active treatment group N = 20 | P-value for between-group comparison |
---|---|---|---|
 | Mean (St Dev) | Mean (St Dev) |  |
Age | 55.7 (10.21) | 55.2 (12.26) | 0.87 |
 | N (%) | N (%) |  |
Education | Â | Â | 0.38 |
 High school or less | 6 (23%) | 8 (40%) |  |
 Some college | 8 (31%) | 4 (20%) |  |
 College degree | 5 (19%) | 6 (30%) |  |
 Post-graduate work or degree | 7 (27%) | 2 (10%) |  |
Marital Status at Enrollment | Â | Â | 0.42 |
 Single, never married | 2 (8%) | 1 (5%) |  |
 Married | 17 (65%) | 16 (80%) |  |
 Separated | 0 (0%) | 1 (5%) |  |
 Divorced | 5 (19%) | 2 (10%) |  |
 Widowed | 2 (8%) | 0 (0%) |  |
Employment Status at Enrollment | Â | Â | 0.45 |
 Working full-time | 13 (50%) | 6 (30%) |  |
 Working part-time or at home | 6 (24%) | 4 (20%) |  |
 Retired | 5 (19%) | 7 (35%) |  |
 Student | 0 (0%) | 1 (5%) |  |
 Disabled | 1 (4%) | 2 (10%) |  |
Breast Cancer Stage at Enrollment: Tumor, Node, Metastasis (TNM) Stage Grouping System | Â | Â | NA |
 Stage 0 Noninvasive ductal carcinoma in situ (DCIS) |  | 1 (4%) |  |
 Stage 1 |  | 5 (25%) |  |
 Stage 2 (a & b) |  | 11 (55%) |  |
 Stage 3 (a) |  | 3 (15%) |  |
 Stage 4 |  | 0 (0%) |  |
Type of chemotherapy by completion of study | Â | Â | 0.047 |
 Cyclophosphamide Methotrexate Fluorouracil (CMF) | 13 (50%) | 3 (15%) |  |
 Taxotere (Docetaxel) | 5 (19%) | 6 (30%) |  |
 None | 8 (31%) | 11 (55%) |  |
History of surgery at time of enrollment | Â | Â | 0.034 |
 Lumpectomy | 10 (38%) | 14 (70%) |  |
 Mastectomy | 16 (62%) | 6 (30%) |  |
History of radiation treatment by completion of study | Â | Â | 0.0012 |
 Yes | 10 (38%) | 20 (100%) |  |
 No | 16 (62%) | 0 (0%) |  |
History of tamoxifen by completion of study | Â | Â | 0.047 |
 Yes | 18 (69% | 8 (40%) |  |
 No | 8 (31%) | 12 (60%) |  |